透過您的圖書館登入
IP:3.136.18.48

摘要


血液透析的適當性提高透析患者的存活率,減少疾病的併發症和死亡率。臨床上評估血液透析劑量的指標為尿素氮降低率(urea reduction ratio, URR)及Kt/V。尿素氮降低率至少要在65%以上,可減少併發症;足夠的血液透析劑量至少要在Kt/V ≥ 1.2,才能維護透析病人的健康。透析場所需每月以標準一致性流程採集血液樣本,以達到數值的準確性。除了單一透析治療的尿素廓清率來評估透析量,仍應評估病人的營養狀態、高血壓、貧血狀態、酸血症、血磷的高低、發炎指數,才更臻完整。

並列摘要


Adequacy of hemodialysis increases the survival rate of the patients on hemodialysis, and reduces the morbidity and mortality rate. Clinically, URR (urea reduction ratio) and Kt/V are parameters that can evaluate the adequacy of hemodialysis. URR should be more than 65% to reduce complication rate. For adequacy of hemodialysis, Kt/V should be equal to or larger than 1.2, to maintain the health status of hemodialysis patients. Dialysis centers should use a consistent, standard protocol to collect blood samples, to achieve accuracy of laboratory data. In addition to Kt/V, we should also evaluate the patients' nutritional status, blood pressure, severity of anemia, extent of metabolic acidosis, serum level of phosphate, and inflammatory markers, to complete assessment of dialysis adequacy.

延伸閱讀